India Pharma Outlook Team | Wednesday, 11 December 2024
The market for pharmaceutical manufacturing equipment is expanding quickly due to the increasing demand for pharmaceuticals, particularly generic medications. Generic medications provide a cost-effective substitute for brand-name drugs and have consequently served as a significant solution for these requirements. Pharmaceutical companies have invested in advanced equipment and technology to enhance the manufacturing process by boosting efficiency.
The worldwide market for pharmaceutical manufacturing equipment is expected to expand from USD 19.41 billion in 2024 to USD 26.94 billion by 2029, achieving a CAGR of 6.8% during the forecast period, according to a recent report by MarketsandMarkets.
The blending and mixing machines accounted for the second largest market share in pharmaceutical equipment manufacturing because they ensure consistency, quality, a notable decrease in mixing time, and accommodate a wide range of viscosities. Their adaptability enables efficient emulsifying, homogenizing, and particle size reduction to enhance drug effectiveness. Additionally, these devices are crafted to comply with strict regulations, featuring designs that enable cleaning and straightforward maintenance, aligned with FDA and cGMP standards. Its cost efficiency will also be boosted by energy savings and enhanced process efficiencies as advancements in digital technology improve monitoring and control.